Testing a nerve block for pain relief in heart surgery patients
Analgesic Efficacy of Rhomboid Intercostal Nerve Block for Minimal Invasive Heart Surgery: A Randomized Controlled Clinical Trial
NA · Koç University · NCT05861804
This study is testing if a nerve block can help reduce pain and the need for pain medication in patients having minimally invasive heart surgery.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 78 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Koç University (other) |
| Locations | 1 site (İstanbul) |
| Trial ID | NCT05861804 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of rhomboid intercostal nerve block (RINB) in reducing pain and opioid consumption in patients undergoing minimal invasive heart surgery (MIHS). Participants will be divided into two groups: one receiving the nerve block before surgery and a control group not receiving it. The study will measure various outcomes, including total opioid use, pain scores, extubation times, ICU length of stay, and opioid-related side effects over a 24-hour postoperative period. The goal is to determine if RINB can improve postoperative recovery and patient satisfaction.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-80 scheduled for minimal invasive heart surgery.
Not a fit: Patients with allergies to local anesthetics, chronic opioid use, or psychiatric disorders may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce pain and opioid use in patients undergoing heart surgery, leading to better recovery outcomes.
How similar studies have performed: Previous studies have shown promising results with similar nerve block techniques, suggesting potential efficacy for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients between the age of 18-80 undergoing minimal invasive heart surgery Exclusion Criteria: * Allergy to local anaesthetics * Chronic opioid use history * Patients with psychiatric disorders * Patients who are not open to communication * Patients with chronic organ failure * Patients that do not give consent * Patients that need emergency surgery within the first 24 hours of the initial surgery
Where this trial is running
İstanbul
- Koc University — İstanbul, Turkey (RECRUITING)
Study contacts
- Study coordinator: Kamil Darçın, MD
- Email: kdarcin@ku.edu.tr
- Phone: +90 505 589 50 99
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Minimal Invasive Heart Surgery, Rhomboid Intercostal Nerve Block, rhomboid intercostal nerve block, minimal invasive heart surgery, cardiac anesthesia